Company news
Artelo Biosciences, Inc. news in 2022
Artelo Biosciences, Inc.'s news releases, calls and decks from 2022, newest first.
Artelo Biosciences Reports Third Quarter 2022 Financial Results and Provides Business Update
November 7, 2022
Artelo Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
August 8, 2022
Artelo Biosciences Completes Enrollment of the First Three Cohorts in its CAReS Study Evaluating ART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss
July 18, 2022
Artelo Biosciences Presents Positive Pre-Clinical Results of ART26.12, a Novel FABP5 Inhibitor, in Alleviating Chemotherapy-Induced Pain
June 26, 2022
Artelo Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update
May 11, 2022
Artelo Biosciences Reports Positive Pre-clinical Results for Lead Program in Cancer-Related Cachexia
April 12, 2022
Artelo Biosciences Reports Four-Month 2021 Financial Results in Connection with its Amended Fiscal Year End and Provides Business Update
March 20, 2022